Transaction in Own Shares

Summary by AI BETAClose X

Bellevue Healthcare Trust PLC announced a transaction in its own shares on November 5, 2025, purchasing 1,000,000 ordinary shares on the London Stock Exchange at an average price of 128.98p per share. The company intends to hold these shares in treasury, bringing its total treasury holdings to 208,905,269 ordinary shares. Following this buyback, the number of ordinary shares in issue, excluding treasury shares, now stands at 106,247,040. This reduction in outstanding shares could positively impact per-share metrics and potentially support the company's stock price.

Disclaimer*

Bellevue Healthcare Trust PLC
06 November 2025
 

 

Bellevue Healthcare Trust plc

Transaction in own shares

 


Bellevue Healthcare Trust plc (the "Company") announces that it purchased the following number of its ordinary shares of 1 penny each on the London Stock Exchange through J.P. Morgan Securities plc.



Date of purchase:

05 November 2025

Number of ordinary shares purchased:

1,000,000

Trading venue

LSE

Average price paid per share:

128.98p



The Company intends to hold the purchased shares in treasury.



Following the above transaction, the Company holds 208,905,269 of its ordinary shares in treasury and has 106,247,040 ordinary shares in issue (excluding treasury shares).



The Company's LEI is: 213800HQ3J3H9YF2UI82




Enquiries:

 

 Bellevue Asset Management (UK) Ltd.

 

 Mark Ghahramani


 Telephone: +44 (0) 203 326 2981




 J.P. Morgan Cazenove

 

 James Bouverat (Sales)


 Telephone: +44 (0) 207 134 2224




NSM Funds (UK) Limited

 

Brian Smith, Ciara McKillop


Contact: bellevue@nsm.group


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings